{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:34:45Z","timestamp":1792362885007,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK020579"],"award-info":[{"award-number":["P30 DK020579"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD060576"],"award-info":[{"award-number":["R01HD060576"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01NS114156"],"award-info":[{"award-number":["U01NS114156"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["ZIAHG200409"],"award-info":[{"award-number":["ZIAHG200409"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003188","name":"National Tay-Sachs and Allied Diseases Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003189","name":"National Tay-Sachs and Allied Diseases Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ebiom.2023.104627","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T07:01:06Z","timestamp":1685516466000},"page":"104627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis"],"prefix":"10.1016","volume":"92","author":[{"given":"Pamela","family":"Kell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-2855","authenticated-orcid":false,"given":"Mingxing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5545-630X","authenticated-orcid":false,"given":"Elena-Raluca","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precilla","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sena- Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Dietzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmilan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean E.","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Ory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-7294","authenticated-orcid":false,"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2023.104627_bib1","series-title":"Rosenberg's molecular and genetic basis of neurological and psychiatric disease 5th edition roger rosenberg juan pascual","first-page":"385","article-title":"Chapter 34: \u03b2-galactosidase deficiency: GM1 gangliosidosis, Morquio B disease, and galactosialidosis","author":"Johnson","year":"2015"},{"key":"10.1016\/j.ebiom.2023.104627_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.734878","article-title":"GM1 gangliosidosis-A mini-review","volume":"12","author":"Nicoli","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.ebiom.2023.104627_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/TACG.S206076","article-title":"GM1 gangliosidosis: mechanisms and management","volume":"14","author":"Rha","year":"2021","journal-title":"Appl Clin Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104627_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"231","key":"10.1016\/j.ebiom.2023.104627_bib5","doi-asserted-by":"crossref","first-page":"231ra48","DOI":"10.1126\/scitranslmed.3007733","article-title":"Sustained normalization of neurological disease after intracranial gene therapy in a feline model","volume":"6","author":"McCurdy","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2023.104627_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.omtm.2019.11.023","article-title":"7T MRI predicts amelioration of neurodegeneration in the brain after AAV gene therapy","volume":"17","author":"Gray-Edwards","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104627_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/brain\/awab309","article-title":"Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis","volume":"145","author":"Gross","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2023.104627_bib8","series-title":"BEST (biomarkers, EndpointS, and other tools) resource","author":"Group. F-NBW","year":"2016"},{"key":"10.1016\/j.ebiom.2023.104627_bib9","series-title":"Guidance for industry: bioanalytical method validations","year":"2018"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104627_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4155\/bio.13.323","article-title":"A\u00a0clinical biomarker assay for the quantification of d3-creatinine and creatinine using LC-MS\/MS","volume":"6","author":"Leonard","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ebiom.2023.104627_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.omtm.2017.07.005","article-title":"Lipidomic evaluation of feline neurologic disease after AAV gene therapy","volume":"6","author":"Gray-Edwards","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104627_bib12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ymthe.2017.01.009","article-title":"Novel biomarkers of human GM1 gangliosidosis reflect the clinical efficacy of gene therapy in a feline model","volume":"25","author":"Gray-Edwards","year":"2017","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104627_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jimd.12269","article-title":"Detection of GM1-gangliosidosis in newborn dried blood spots by enzyme activity and biomarker assays using tandem mass spectrometry","volume":"44","author":"Su","year":"2021","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104627_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ab.2005.06.042","article-title":"Profiling oligosaccharidurias by electrospray tandem mass spectrometry: quantifying reducing oligosaccharides","volume":"345","author":"Ramsay","year":"2005","journal-title":"Anal Biochem"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104627_bib15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/rcm.7860","article-title":"Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses","volume":"31","author":"Piraud","year":"2017","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.ebiom.2023.104627_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-9-19","article-title":"Fast urinary screening of oligosaccharidoses by MALDI-TOF\/TOF mass spectrometry","volume":"9","author":"Bonesso","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104627_bib17","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/clinchem\/44.12.2422","article-title":"Identification of urinary oligosaccharides by matrix-assisted laser desorption ionization time-of-flight mass spectrometry","volume":"44","author":"Klein","year":"1998","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104627_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1373\/clinchem.2012.201053","article-title":"Oligosaccharide analysis in urine by maldi-tof mass spectrometry for the diagnosis of lysosomal storage diseases","volume":"59","author":"Xia","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.ebiom.2023.104627_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ab.2014.04.019","article-title":"Single tag for total carbohydrate analysis","volume":"457","author":"Anumula","year":"2014","journal-title":"Anal Biochem"},{"issue":"1-2","key":"10.1016\/j.ebiom.2023.104627_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchromb.2005.10.006","article-title":"Oligosaccharide analysis by capillary-scale high-pH anion- exchange chromatography with on-line ion-trap mass spectrometry","volume":"829","author":"Bruggink","year":"2005","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ebiom.2023.104627_bib21","first-page":"782","article-title":"Structure analysis of branched oligosaccharides using post-source decay in matrix-assisted laser desorption ionization mass spectrometry","volume":"30","author":"Spengler","year":"1995","journal-title":"J\u00a0Mass Spectrom"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104627_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1044-0305(93)85081-8","article-title":"Collision-induced dissociation of alkali metal cationized and permethylated oligosaccharides: influence of the collision energy and of the collision gas for the assignment of\u00a0linkage position","volume":"4","author":"Lemoine","year":"1993","journal-title":"J\u00a0Am Soc Mass Spectrom"},{"key":"10.1016\/j.ebiom.2023.104627_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0008-6215(00)81048-4","article-title":"The structures of six urinary oligosaccharides that are characteristic for a patient with Morquio syndrome type B","volume":"100","author":"Michalski","year":"1982","journal-title":"Carbohydr Res"},{"issue":"42","key":"10.1016\/j.ebiom.2023.104627_bib24","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.1039\/C7OB02303K","article-title":"Decoding glycan protein interactions by a new class of asymmetric N-glycans","volume":"15","author":"Wu","year":"2017","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.ebiom.2023.104627_bib25","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1039\/P19810002070","article-title":"Synthesis of a tri-, a penta-, and a hepta-saccharide containing terminal N-acetyl-\u03b2-D- lactosaminyl residues, part of the 'complex-type' carbohydrate moiety of glycoproteins","author":"Arnarp","year":"1981","journal-title":"J\u00a0Chem Soc Perkin Trans I"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104627_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mas.21607","article-title":"Strategies and challenges in method development and validation for the absolute quantification of endogenous biomarker metabolites using liquid chromatography-tandem mass spectrometry","volume":"40","author":"Khamis","year":"2021","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.ebiom.2023.104627_bib27","series-title":"GeneReviews\u00ae","first-page":"1993","article-title":"GLB1-Related disorders","author":"Regier","year":"2013"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104627_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymgme.2014.11.015","article-title":"Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses","volume":"114","author":"Utz","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104627_bib29","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ajmg.a.37468","article-title":"MRI\/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis","volume":"170","author":"Regier","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104627_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02043310","article-title":"Neurophysiological studies in GM1, gangliosidosis","volume":"3","author":"Harden","year":"1982","journal-title":"Ital J Neurol Sci"},{"issue":"Suppl","key":"10.1016\/j.ebiom.2023.104627_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2008-1052386","article-title":"Neurophysiological investigations in GM1 and GM2 gangliosidoses","volume":"15","author":"Pampiglione","year":"1984","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104627_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11011-019-0391-y","article-title":"A\u00a0possible biomarker of neurocytolysis in infantile gangliosidoses: aspartate transaminase","volume":"34","author":"Kilic","year":"2019","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.ebiom.2023.104627_bib33","article-title":"Characterization of glycan substrates accumulating in GM1 Gangliosidosis","volume":"21","author":"Lawrence","year":"2019","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104627_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.brainres.2006.11.039","article-title":"Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen","volume":"1133","author":"Satoh","year":"2007","journal-title":"Brain Res"},{"issue":"5-6","key":"10.1016\/j.ebiom.2023.104627_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clinbiochem.2006.12.003","article-title":"Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease","volume":"40","author":"Wajner","year":"2007","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104627_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10545-005-0089-7","article-title":"Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis","volume":"28","author":"Shield","year":"2005","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104627_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.braindev.2012.12.002","article-title":"Chaperone therapy update: fabry disease, GM1-gangliosidosis and Gaucher disease","volume":"35","author":"Suzuki","year":"2013","journal-title":"Brain Dev"},{"issue":"23","key":"10.1016\/j.ebiom.2023.104627_bib38","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.2217\/nnm-2017-0221","article-title":"Polyethylene glycol-b-poly(lactic acid) polymersomes as vehicles for enzyme replacement therapy","volume":"12","author":"Kelly","year":"2017","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104627_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ymgme.2015.12.002","article-title":"Enzyme replacement for GM1-gangliosidosis: uptake, lysosomal activation, and cellular disease correction using a novel beta-galactosidase:RTB lectin fusion","volume":"117","author":"Condori","year":"2016","journal-title":"Mol Genet Metab"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:24:27Z","timestamp":1762457067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":39,"alternative-id":["S2352396423001925"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104627","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104627"}}